Cart
sales@molnova.com
Seralutinib
CAS No. 1619931-27-9
Seralutinib( GB002 )
Catalog No. M23717 CAS No. 1619931-27-9
Seralutinib is an inhibitor of inhaled PDGFRα and PDGFRβ. It is used in the study for pulmonary arterial hypertension.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 61 | In Stock |
|
| 5MG | 102 | In Stock |
|
| 10MG | 160 | In Stock |
|
| 25MG | 309 | In Stock |
|
| 50MG | 485 | In Stock |
|
| 100MG | 700 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSeralutinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionSeralutinib is an inhibitor of inhaled PDGFRα and PDGFRβ. It is used in the study for pulmonary arterial hypertension.
-
DescriptionSeralutinib is an inhibitor of inhaled PDGFRα and PDGFRβ. It is used in the study for pulmonary arterial hypertension.
-
In Vitro——
-
In Vivo——
-
SynonymsGB002
-
PathwayAngiogenesis
-
TargetPDGFR
-
RecptorPDGFRα|PDGFRβ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1619931-27-9
-
Formula Weight469.55
-
Molecular FormulaC27H27N5O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL?(212.98 mM;?Need ultrasonic)
-
SMILESCC1=CC(=CN=C1)C(=O)NC2=CC=CC(=C2)[C@H](C)NC3=NC(=CN=C3)C4=CC(=C(C=C4)OC)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Anna Galkin, et al. Pharmacologic Characterization of GB002, a Novel Inhaled PDGFR Kinase Inhibitor in Development for Pulmonary Arterial Hypertension (PAH).
molnova catalog
related products
-
Olaratumab
Olaratumab(IMC-3G3) is a human monoclonal IgG1 antibody against platelet-derived growth factor receptor alpha (PDGFRα), which has antitumor effects and can be used to study advanced soft tissue sarcomas.
-
GF109203X
GF109203X is a potent PKC inhibitor with IC50 of 20 nM, 17 nM, 16 nM, and 20 nM for PKCα, PKCβI, PKCβII, and PKCγ, respectively.
-
BMS-5
BMS-5 is a potent LIMK inhibitor with IC50s of 7 nM and 8 nM for LIMK1 and LIMK2, respectively.
